HFM Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02K Buy
30
+13
+76% +$866 ﹤0.01% 452
2026
Q1
$1.07K Buy
17
+9
+113% +$627 ﹤0.01% 389
2025
Q4
$531 Buy
8
+3
+60% +$194 ﹤0.01% 699
2025
Q3
$336 Buy
5
+1
+25% +$79 ﹤0.01% 822
2025
Q2
$349 Buy
4
+3
+300% +$235 ﹤0.01% 789
2025
Q1
$69 Buy
+1
New +$82 ﹤0.01% 966

Other funds holding DXCM

HFM Investment Advisors's DXCM Position: Q2 2026 in Review

HFM Investment Advisors increased its DexCom (DXCM) stake by 76% in Q2 2026, buying an estimated $866 and bringing the position to 30 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #452.

HFM Investment Advisors first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HFM Investment Advisors held 30 shares of DexCom worth $2.02K as of Q2 2026.
  • HFM Investment Advisors bought 13 DexCom shares in Q2 2026, an estimated $866.
  • DexCom made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #452 holding.
  • HFM Investment Advisors first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.